To Wednesday 18 October 2017
These are exciting times for the science of pharmacovigilance. The theme of the conference will capture innovations that are occurring in many domains, and focus on how they can bring about benefits for patients.
Spontaneous reporting systems remain the cornerstone of pharmacovigilance. Specific innovations to improve reporting include patient reports, and electronic methods of reporting including the development of apps. These electronic methods are likely to be facilitated by the likely rise in smartphone usage (estimated to be over 2.6 billion people by 2018) allowing the possibility to capture drug safety information in real-time.
There is also a growth in the use of social media and social networks, which allows further opportunities to identify drug safety issues directly from patients – this in itself leads to many challenges for healthcare professionals, industry and regulators, and will need to be accompanied by the development of analytical platforms for big data, including innovative data mining algorithms, underpinned by developments in regulation.
The conference programme will address the latest trends in pharmacovigilance and how they can be harnessed for patient benefit in the 21st century and beyond.